Login / Signup

In Situ Visualization of PD-L1-Specific Glycosylation on Tissue Sections.

Mengjiao HuangLin ZhuSiyin KangFude ChenXinyu WeiLiyuan LinXiaofeng ChenWei WangZhi ZhuChaoyong James YangYanLing Song
Published in: Analytical chemistry (2021)
Immune checkpoint therapy has provided a weapon against cancer, but its response rate has been extremely low due to the lack of effective predictors. Herein, we developed a FRET strategy based on lectin for glycan labeling and an aptamer for PD-L1 antigen recognition for visualization of PD-L1-specific glycosylation (FLAG). The FLAG strategy combines the PD-L1 aptamer, which efficiently labels the PD-L1 polyantigen with smaller steric hindrance than the PD-L1 antibody, and metabolism-free lectin labeling for glycosylation. As a result, the FLAG strategy enables in situ visualization of PD-L1-specific glycosylation on the tissue section while maintaining the spatial context and tissue architecture. Due to nonmetabolic labeling, the FLAG strategy revealed that the tissue level of PD-L1-specific glycosylation is correlated with the efficacy of PD-1/PD-L1 therapy. Overall, the FLAG strategy provides a powerful tool for revealing the significance of PD-L1 glycosylation, offering the unprecedented potential for immunophenotypic differential analysis to predict the immunotherapy response.
Keyphrases
  • gold nanoparticles
  • stem cells
  • sensitive detection
  • squamous cell carcinoma
  • papillary thyroid
  • single cell
  • risk assessment
  • mesenchymal stem cells
  • squamous cell
  • data analysis